This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Three imaging strategies were compared with a baseline strategy of medical therapy for all patients.
The three strategies were video-electroencephalography monitoring (VEM) with magnetic resonance imaging (MRI); VEM+MRI with ictal (during seizure) single photon emission computed tomography (SPECT) for those patients with indeterminate VEM+MRI; and VEM+MRI plus interictal (between seizures) 18 F-FDG PET for those patients with indeterminate VEM+MRI.
Location/setting
Australia/hospital.
Methods Analytical approach:
A decision tree model with a 39-month median time horizon was used. The authors stated that the perspective was that of an Australian purchaser.
Effectiveness data:
The effectiveness data were mostly based on a cross-sectional sample of 176 patients, who underwent 18 F-FDG PET as part of their pre-surgical evaluation, although some data were derived from other studies. The "gold standard of lesion localisation" was derived through consensus by a group of experts, who were presented with all of the test information. The main outcomes were localisation rates, patient's status defined using a modified Engel scale to assign a postsurgical outcome of good (class I or II) or poor (class III or IV), and the characteristics and concordance of the tests.
Monetary benefit and utility valuations:
Not relevant.
Measure of benefit:

